J Gynecol Oncol.
2021 Nov;32(6):e94. 10.3802/jgo.2021.32.e94.
Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
- 2Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea
- 3Department of Obstetrics and Gynecology, Keimyung University School of Medicine, Daegu, Korea
- 4Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea
- 5Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea
- 6Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea
- 7Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Yangsan, Korea
- 8Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 9Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 10Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 11Department of Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea
- KMID: 2526283
- DOI: http://doi.org/10.3802/jgo.2021.32.e94
Abstract
- Since the human papillomavirus (HPV) vaccine guidelines were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2011, 2016, and 2019, several recent studies on the efficacy and safety of HPV vaccines in middle-aged women and men have been reported. Furthermore, there has been an ongoing debate regarding the efficacy of the HPV vaccine in women with prior HPV infection or who have undergone conization for cervical intraepithelial neoplasia (CIN). We searched and reviewed studies on the efficacy and safety of the HPV vaccine in middle-aged women and men and the efficacy of the HPV vaccine in patients infected with HPV and those who underwent conization for CIN. The KSGO updated their guidelines based on the results of the studies included in this review.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline
- Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline
- Efficacy of human papillomavirus vaccines including cross protection : A review of recent evidence
- Human papillomavirus: wearisome or awesome issue?
- The role of human papillomavirus testing after treatment for high-grade cervical dysplasia
